However, both alterations are scarce in LC and LCNEC tumors [5, 6, 14–16], consistent with our findings of no EGFR mutations or validated ALK gene fusions in either LC or LCNEC tumors. This evidence concerns the gene EGFR and laryngotracheoesophageal cleft.